morpholine has been researched along with Colonic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdollahi, E; Hosseini-Kharat, M; Mehri Lighvan, Z; Mohammadi, T; Momtazi-Borojeni, AA; Rahimi, R; Sharifi, T; Tavakol, H; Zargarian, D | 1 |
Gupta, S; Hnatowich, DJ; Liu, G; Liu, N; Mang'era, K; Rusckowski, M | 1 |
2 other study(ies) available for morpholine and Colonic Neoplasms
Article | Year |
---|---|
Antiproliferative activity of morpholine-based compounds on MCF-7 breast cancer, colon carcinoma C26, and normal fibroblast NIH-3T3 cell lines and study of their binding affinity to calf thymus-DNA and bovine serum albumin.
Topics: Animals; Binding Sites; Breast Neoplasms; Cattle; Cell Death; Cell Proliferation; Circular Dichroism; Colonic Neoplasms; Density Functional Theory; DNA; Female; Fibroblasts; Humans; Kinetics; MCF-7 Cells; Mice; Molecular Docking Simulation; Morpholines; NIH 3T3 Cells; Nucleic Acid Denaturation; Serum Albumin, Bovine; Thermodynamics | 2019 |
Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
Topics: Animals; Carcinoembryonic Antigen; Colonic Neoplasms; Mice; Mice, Nude; Molecular Weight; Morpholines; Neoplasm Transplantation; Oligonucleotides; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Mertiatide; Tissue Distribution; Tumor Cells, Cultured | 2002 |